US drugmaker Merck, known in Brazil as MSD, announced Friday (1) that it intends to obtain approval in the United States for a drug against Covid-19: molnupirvir. A study conducted by the company showed that the drug reduced by about 50% the chance of hospitalization or death in patients at risk of developing severe forms of the disease.
If approved, it would become the first pill drug to be effective in treating the disease — unlike drugs such as hydroxychloroquine and ivermectin, which are touted by pandemic deniers.
Monday’s breakfast episode (4) with the participation of a scientific reporter from a sheet and Repudia Immune podcast host, Reinaldo Jose Lopez. He explains the difficulty of producing Covid-19 drugs and how they can help fight the pandemic.
Listen to the episode:
The podcast is published on Spotify, .’s partner streaming service a sheet In the initiative and specializing in music, podcasts and video. You can listen to the episode by clicking below. To access the app just sign up for free.
Café da Manhã is published from Monday to Friday, always at the beginning of the day. The episode was presented by journalists Maggie Flores and Mauricio Meirelles. Screenplay by Angela Boldrini. Produced by Jessica Maes, Laila Al Moallem and Victor Lacombe. Audio editing by Thomé Granemann and Natália Silva.
Andrea Hargraves is a contributor to Brytfmonline.com, covering a broad range of topics including news, politics, business, technology, sports, entertainment, and lifestyle. She is committed to delivering clear, accurate, and reader-focused reporting that helps audiences stay informed about current events and emerging developments. Andrea’s work emphasizes useful information, balanced coverage, and stories that matter to everyday readers, making complex topics accessible and relevant to a wide audience.